The Allstate Corp:企業の戦略・SWOT・財務情報

◆英語タイトル:The Allstate Corp - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C14385
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Allstate Corp – Strategy, SWOT and Corporate Finance Report
Summary

The Allstate Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Allstate Corp (Allstate) is a provider of insurance products. The company, along with its subsidiaries, offers a range of life, non-life and health insurance products under the brands including Esurance, Allstate and Encompass, to individuals and corporate clients. Allstate offers insurance products for auto, boat, home, renters, snowmobile, condo, motorcycle, pet, event and landlord. It also offers business insurance, term life insurance, whole life insurance, universal life insurance, annuities, individual retirement accounts (IRAs), mutual funds, accident and disability insurance and critical illness insurance. It sells and distributes its products through agencies, financial representatives, independent agents, contact centers and the internet in the US and Canada. Allstate is headquartered in Northbrook, Illinois, the US.

Allstate reported premiums earned of US$37,452 million for the fiscal year ended December 2018 (FY2018), an increase of 8% over that in FY2017.

Scope

- Detailed information on The Allstate Corp required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Allstate Corp in the form of a SWOT analysis
- An in-depth view of the business model of The Allstate Corp including a breakdown and examination of key business segments
- Intelligence on The Allstate Corp’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Allstate Corp, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Allstate Corp and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Allstate Corp as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Allstate Corp’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
The Allstate Corp: Company Overview
The Allstate Corp: Overview and Key Facts
The Allstate Corp: Overview
The Allstate Corp: Key Facts
The Allstate Corp: Key Employees
The Allstate Corp: Key Employee Biographies
The Allstate Corp: Major Products and Services
The Allstate Corp: Company History
The Allstate Corp: Management Statement
The Allstate Corp: Locations and Subsidiaries
The Allstate Corp: Key Competitors
The Allstate Corp: Company Analysis
The Allstate Corp: Business Description
The Allstate Corp: SWOT Analysis
The Allstate Corp: SWOT Overview
The Allstate Corp: Strengths
The Allstate Corp: Weaknesses
The Allstate Corp: Opportunities
The Allstate Corp: Threats
The Allstate Corp: Corporate Financial Deals Activity
The Allstate Corp: Financial Deals Overview
The Allstate Corp: Targets and Partners
The Allstate Corp: Top Deals 2015 – 2019YTD*
The Allstate Corp: Advisors
The Allstate Corp: Top Legal Advisors
The Allstate Corp: Top Financial Advisors
The Allstate Corp: Mergers and Acquisitions
The Allstate Corp: Capital Raising
The Allstate Corp: Recent Developments
The Allstate Corp: News and Events Summary
The Allstate Corp: Business Expansion
The Allstate Corp: Contracts
The Allstate Corp: Corporate Governance
The Allstate Corp: Financial Performance
The Allstate Corp: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: The Allstate Corp: Key Facts
Table 2: The Allstate Corp: Key Employees
Table 3: The Allstate Corp: Company History
Table 4: The Allstate Corp: Locations and Subsidiaries
Table 5: The Allstate Corp: Key Competitors
Table 6: The Allstate Corp: Deal Activity by Deal Type - Volume (TTM*)
Table 7: The Allstate Corp: M&A Activity by Geography (TTM*)
Table 8: The Allstate Corp: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: The Allstate Corp: M&A Average Deal Size - Value (US$m)
Table 10: The Allstate Corp: Targets and Partners
Table 11: The Allstate Corp: Top Deals 2015 - 2019YTD*
Table 12: The Allstate Corp: Legal Advisor Ranking by Value (US$m)
Table 13: The Allstate Corp: Financial Advisor Ranking by Value (US$m)
Table 14: The Allstate Corp: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: The Allstate Corp: M&A Activity by Geography (2015 - YTD*2019)
Table 16: The Allstate Corp: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 17: The Allstate Corp: Capital Raising by Deal Type (2015 - YTD*2019)
Table 18: The Allstate Corp: News and Events Summary
Table 19: The Allstate Corp: Business Expansion
Table 20: The Allstate Corp: Contracts
Table 21: The Allstate Corp: Corporate Governance
Table 22: The Allstate Corp: Financial Performance
Table 23: The Allstate Corp: Strategy and Operations

List of Figures
Figure 1: The Allstate Corp: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Allstate Corp: M&A Activity by Geography (TTM*)
Figure 3: The Allstate Corp: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: The Allstate Corp: M&A Average Deal Size - Value (US$m)
Figure 5: The Allstate Corp: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: The Allstate Corp: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: The Allstate Corp: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 8: The Allstate Corp: Capital Raising by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[The Allstate Corp:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fuji Seal International Inc.:戦略・SWOT・企業財務分析
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Clinova Ltd:企業の戦略的SWOT分析
    Clinova Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • GW Pharmaceuticals Plc (GWPH):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Stellar Biotechnologies Inc (SBOT):企業の財務・戦略的SWOT分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Sino Oil and Gas Holdings Ltd (702):企業の財務・戦略的SWOT分析
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • Royal DSM NV (DSM)-医療機器分野:企業M&A・提携分析
    Summary Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. It pr …
  • LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析
    LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nido Petroleum Limited:石油・ガス:M&Aディール及び事業提携情報
    Summary Nido Petroleum Limited (Nido), a subsidiary of BCP Energy International Pte. Ltd, is an upstream energy company. It explores for, develops, and produces oil and gas. Nido holds working interests in exploration permits in the North West Palawan basin of the Philippines. The company operates t …
  • MorphoSys AG (MOR):企業の財務・戦略的SWOT分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, and research applications. The company’s pipeline products include MOR208, MOR103, MOR202, MAA868, VAY736, MOR106, and MOR107. Its drugs are used for the treatment of various types of cancers, psoriasis, rheuma …
  • Abide Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abide Therapeutics Inc (Abide) is a clinical development stage company that discovers and develops therapeutic potential of serine hydrolases to transform the lives of patients with serious unmet medical needs. The company’s pipeline include ABX-1431, a first-in-class inhibitor of the serine …
  • Extendicare Inc.:企業の戦略・SWOT・財務情報
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Invectys SA-製薬・医療分野:企業M&A・提携分析
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company’s product pipeline includes INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine (UCPVax), a human telomerase peptide-based vaccine; INMAB-1, a monoclonal a …
  • Covance Inc:企業の戦略的SWOT分析
    Covance Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Hovid Berhad (HOVID):企業の財務・戦略的SWOT分析
    Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CarrefourSA A.S. (CRFSA):企業の財務・戦略的SWOT分析
    CarrefourSA A.S. (CRFSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Teva Pharmaceutical Industries Ltd (TEVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • Welspun India Ltd (WELSPUNIND):企業の財務・戦略的SWOT分析
    Welspun India Ltd (WELSPUNIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Waagner-Biro Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Furukawa Electric Co., Ltd.:企業の戦略・SWOT・財務情報
    Furukawa Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Furukawa Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Aster DM Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as cardiac surgery, mobile medical units, village adoption, early cancer detection centers and dialysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆